Top Markets
Coin of the day
Gelesis Holdings, Inc. Gelesis Holdings, Inc.

Gelesis Holdings, Inc.

GLS
Rangering i aksjer #40695
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Aksjekurs
$0.0121
Sist synkronisert: 2023-05-23
Markedsverdi
$97.54K
Endring (1 dag)
-24.38%
Endring (1 år)
0.00%
Land
US
Handel Gelesis Holdings, Inc. (GLS)

Kategori

Utbyttehistorikk for Gelesis Holdings, Inc. (GLS)
Gelesis Holdings, Inc. (aksjesymbol: GLS) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Gelesis Holdings, Inc. (GLS) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
29.00%
BE